These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17981635)

  • 1. Measles vaccines.
    Griffin DE; Pan CH; Moss WJ
    Front Biosci; 2008 Jan; 13():1352-70. PubMed ID: 17981635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles: old vaccines, new vaccines.
    Griffin DE; Pan CH
    Curr Top Microbiol Immunol; 2009; 330():191-212. PubMed ID: 19203111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles Vaccine.
    Griffin DE
    Viral Immunol; 2018 Mar; 31(2):86-95. PubMed ID: 29256824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against challenge with measles virus (MV) in infant macaques by an MV DNA vaccine administered in the presence of neutralizing antibody.
    Premenko-Lanier M; Rota PA; Rhodes GH; Bellini WJ; McChesney MB
    J Infect Dis; 2004 Jun; 189(11):2064-71. PubMed ID: 15143474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates.
    Rennick LJ; de Vries RD; Carsillo TJ; Lemon K; van Amerongen G; Ludlow M; Nguyen DT; Yüksel S; Verburgh RJ; Haddock P; McQuaid S; Duprex WP; de Swart RL
    J Virol; 2015 Feb; 89(4):2192-200. PubMed ID: 25473055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice.
    Combredet C; Labrousse V; Mollet L; Lorin C; Delebecque F; Hurtrel B; McClure H; Feinberg MB; Brahic M; Tangy F
    J Virol; 2003 Nov; 77(21):11546-54. PubMed ID: 14557640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.
    Julik E; Reyes-Del Valle J
    J Virol; 2016 Jun; 90(11):5270-5279. PubMed ID: 26984727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine.
    Whittle HC; Rowland MG; Mann GF; Lamb WH; Lewis RA
    Lancet; 1984 Oct; 2(8407):834-7. PubMed ID: 6148572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine-induced measles virus-specific T cells do not prevent infection or disease but facilitate subsequent clearance of viral RNA.
    Lin WH; Pan CH; Adams RJ; Laube BL; Griffin DE
    mBio; 2014 Apr; 5(2):e01047. PubMed ID: 24736226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against acute respiratory virus infections and measles in man.
    Osterhaus AD; de Vries P
    Immunobiology; 1992 Feb; 184(2-3):180-92. PubMed ID: 1587542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats.
    Pasetti MF; Barry EM; Losonsky G; Singh M; Medina-Moreno SM; Polo JM; Ulmer J; Robinson H; Sztein MB; Levine MM
    J Virol; 2003 May; 77(9):5209-17. PubMed ID: 12692223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental vaccines against measles in a world of changing epidemiology.
    Pütz MM; Bouche FB; de Swart RL; Muller CP
    Int J Parasitol; 2003 May; 33(5-6):525-45. PubMed ID: 12782053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live attenuated measles vaccine as a potential multivalent pediatric vaccination vector.
    Tangy F; Naim HY
    Viral Immunol; 2005; 18(2):317-26. PubMed ID: 16035943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuated measles virus as a vaccine vector.
    Zuniga A; Wang Z; Liniger M; Hangartner L; Caballero M; Pavlovic J; Wild P; Viret JF; Glueck R; Billeter MA; Naim HY
    Vaccine; 2007 Apr; 25(16):2974-83. PubMed ID: 17303293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines.
    Martins C; Garly ML; Bale C; Rodrigues A; Benn CS; Whittle H; Aaby P
    Vaccine; 2013 Nov; 31(48):5766-71. PubMed ID: 23994379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A paediatric vaccination vector based on live attenuated measles vaccine.
    Lorin C; Combredet C; Labrousse V; Mollet L; Desprès P; Tangy F
    Therapie; 2005; 60(3):227-33. PubMed ID: 16128264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects for the eradication of infectious diseases.
    Stuart-Harris C
    Rev Infect Dis; 1984; 6(3):405-11. PubMed ID: 6377445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans.
    Etchart N; Hennino A; Friede M; Dahel K; Dupouy M; Goujon-Henry C; Nicolas JF; Kaiserlian D
    Vaccine; 2007 Sep; 25(39-40):6891-9. PubMed ID: 17764789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines.
    Markowitz LE; Sepulveda J; Diaz-Ortega JL; Valdespino JL; Albrecht P; Zell ER; Stewart J; Zarate ML; Bernier RH
    N Engl J Med; 1990 Mar; 322(9):580-7. PubMed ID: 2304505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles.
    Polack FP; Lee SH; Permar S; Manyara E; Nousari HG; Jeng Y; Mustafa F; Valsamakis A; Adams RJ; Robinson HL; Griffin DE
    Nat Med; 2000 Jul; 6(7):776-81. PubMed ID: 10888926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.